Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Wave Life Sciences, Duchenne muscular dystrophy
Wave Life Sciences’ stock soars 51% after biotech posts positive data from Duchenne muscular-dystrophy trial
Biotech reported positive interim data from a mid-stage trial of a treatment for the rare muscle disorder Duchenne muscular dystrophy.
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, announced today that it has commenced an underwritten public offering of $175 million in aggregate of its ordinary shares,
Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug
Wave Life Sciences Ltd. (NASDAQ:WVE) revealed interim data from the ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne muscular dystrophy (DMD) patients amenable to exon 53 skipping. DMD is a genetic disease that causes progressive muscle weakness and degeneration caused by a mutation in the dystrophin gene.
Wave Life Sciences: Spiking On Strong DMD Data, But Not Fully De-Risked Yet
Wave Life Sciences stock surged over 50% today due to promising data from its Duchenne Muscular Dystrophy candidate WVE-N531. Explore more details here.
Wave Life Sciences, Nio, Li Auto, Tesla And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling around 200 points on Friday. Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) rose sharply during Tuesday's session after the company announced interim data from its ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne muscular dystrophy.
Buy Rating on Wave Life Sciences: Undervalued DMD Program and Promising Data Offer Investment Upside
Analyst Tiago Fauth from Wells Fargo maintained a Buy rating on Wave Life Sciences (WVE – Research Report) and keeping the price target
Wave Life Sciences Ltd. (Nasdaq: WVE) Gains on Clinical Trial News
The stock is trading at $8.18, up $2.84, gaining 53.18% on volume of over 12.4 Million shares. The stock had a days' high of $8.33.
Wave Life Sciences gains on data for Duchenne therapy
Wave Life Sciences (WVE) stock rises on positive interim data from a Phase 2 trial for for WVE-N531, a therapy for Duchenne muscular dystrophy (DMD). Read more here.
Wave Life And Capricor Surge Forward With Hope - Are These Stocks In Your Portfolio?
Duchenne muscular dystrophy, or DMD, is a severe genetic disorder, typically affecting males, and is characterized by progressive
Wave Life Sciences Shares Climb Premarket on Duchenne Study Data
Shares of Wave Life Sciences rose more than 10% in premarket trading Tuesday after the clinical-stage biotechnology company reported positive interim data from a mid-stage study of its WVE-N531 drug candidate in the neuromuscular genetic disease Duchenne muscular dystrophy.
FierceBiotech
13h
Wave surfs DMD success to regulators' doors, sending stock up
Wave’s result is in line with the data that supported accelerated approval of NS Pharma’s exon 53 DMD drug Viltepso. NS ...
Yahoo Finance
1d
Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely?
So, the natural question for
Wave
Life
Sciences
(NASDAQ:WVE) shareholders is whether they should be concerned by its ...
STAT
14h
Metsera’s GLP-1 drug has potential for monthly dosing, new data show
Novo Nordisk CEO Lars Fruergaard Jørgensen will testify at a Senate hearing today about the prices of Ozempic and Wegovy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Would-be assassin charged
Gets 2-yrs for role in fraud
Diagnosed with Parkinson's
Woman dies in 'suicide pod’
‘Trump Train’ jury verdict
Food packaging cancer risk
Haitian group files complaint
Outlaws guitarist dies
Contempt charge coming?
Won't call special session
Rioter mistakenly released
Phoenix breaks heat record
To shut down TikTok Music
1st NL East title since 2011
Foreign incentives offer?
Executed by lethal injection
ISR: Hezbollah leader killed
Dali owner, operator sued
PA county ballot ruling
EEOC blocked on rules
Partners with Google
Calls for US to lift sanctions
NC sending absentee ballots
X account hacked
Pac-12 sues Mountain West
Retiring after 14 seasons
Johnny Cash statue unveiled
Recalls 41K+ motorcycles
Study about oceans' acidity
Severe obesity on the rise
OR removes 1,200+ voters
Related topics
Duchenne muscular dystrophy
WVE-N531
Feedback